Public-registry trials using AUR101 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3) | Aurigene Discovery Technologies Limited | Plaque Psoriasis | PHASE2 | 25 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →